NantHealth Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
NantHealth's earnings have been declining at an average annual rate of -19.6%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been declining at an average rate of 1.9% per year.
Anahtar bilgiler
-19.6%
Kazanç büyüme oranı
3.5%
EPS büyüme oranı
Healthcare Services Sektör Büyümesi | 1.7% |
Gelir büyüme oranı | -1.9% |
Özkaynak getirisi | n/a |
Net Marj | -109.5% |
Son Kazanç Güncellemesi | 30 Sep 2023 |
Yakın geçmiş performans güncellemeleri
Recent updates
Investors Aren't Buying NantHealth, Inc.'s (NASDAQ:NH) Revenues
Apr 17NantHealth GAAP EPS of -$0.11, revenue of $16.5M
Aug 04Ronald Louks Is The Chief Operating Officer of NantHealth, Inc. (NASDAQ:NH) And They Just Sold 26% Of Their Shares
Mar 18Time To Worry? Analysts Are Downgrading Their NantHealth, Inc. (NASDAQ:NH) Outlook
Mar 06If You Had Bought NantHealth (NASDAQ:NH) Shares A Year Ago You'd Have Earned 183% Returns
Feb 04NantHealth jumps after study highlights the utility of its decision-support platform
Dec 11Gelir ve Gider Dağılımı
NantHealth nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Sep 23 | 64 | -70 | 55 | 19 |
30 Jun 23 | 68 | -69 | 63 | 23 |
31 Mar 23 | 68 | -64 | 64 | 22 |
31 Dec 22 | 67 | -68 | 63 | 23 |
30 Sep 22 | 66 | -59 | 60 | 23 |
30 Jun 22 | 63 | -56 | 57 | 21 |
31 Mar 22 | 63 | -59 | 55 | 20 |
31 Dec 21 | 63 | -58 | 52 | 20 |
30 Sep 21 | 65 | -62 | 49 | 19 |
30 Jun 21 | 70 | -62 | 48 | 19 |
31 Mar 21 | 71 | -95 | 49 | 19 |
31 Dec 20 | 73 | -88 | 49 | 17 |
30 Sep 20 | 73 | -81 | 50 | 16 |
30 Jun 20 | 73 | -86 | 51 | 14 |
31 Mar 20 | 75 | -55 | 53 | 14 |
31 Dec 19 | 77 | -65 | 56 | 14 |
30 Sep 19 | 82 | -101 | 57 | 16 |
30 Jun 19 | 85 | -183 | 61 | 17 |
31 Mar 19 | 87 | -188 | 65 | 20 |
31 Dec 18 | 89 | -190 | 71 | 21 |
30 Sep 18 | 89 | -164 | 77 | 25 |
30 Jun 18 | 88 | -89 | 77 | 28 |
31 Mar 18 | 90 | -125 | 78 | 30 |
31 Dec 17 | 87 | -131 | 75 | 34 |
30 Sep 17 | 82 | -157 | 71 | 36 |
30 Jun 17 | 81 | -161 | 75 | 38 |
31 Mar 17 | 80 | -138 | 95 | 46 |
31 Dec 16 | 80 | -145 | 105 | 47 |
30 Sep 16 | 83 | -131 | 105 | 39 |
30 Jun 16 | 77 | -128 | 102 | 36 |
31 Mar 16 | 66 | -110 | 80 | 25 |
31 Dec 15 | 46 | -62 | 56 | 14 |
30 Sep 15 | 48 | -84 | 66 | 21 |
30 Jun 15 | 43 | -91 | 62 | 18 |
31 Mar 15 | 39 | -86 | 53 | 17 |
31 Dec 14 | 34 | -84 | 46 | 17 |
31 Dec 13 | 27 | -41 | 35 | 11 |
Kaliteli Kazançlar: NHIQ is currently unprofitable.
Büyüyen Kar Marjı: NHIQ is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: Insufficient data to determine if NHIQ's year-on-year earnings growth rate was positive over the past 5 years.
Büyüme Hızlandırma: Unable to compare NHIQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: NHIQ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.1%).
Özkaynak Getirisi
Yüksek ROE: NHIQ's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.